Cargando…

The dose response of sufentanil as an adjuvant to ropivacaine in cesarean section for relief from somato-visceral pain under epidural anesthesia in parturients with scarred uterus

Visceral pain is common during epidural anesthesia with mini dose local anesthetics in parturients during cesarean section. To reduce or avoid this complication caused by traction on the abdominal viscera, this study aimed to determine the 50% effective dose (ED(50)) and 95% effective dose (ED(95))...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Qiang, Dong, Chun-shan, Yu, Jun-Ma, Sun, Hao, Sun, Peng, Ma, Xiang, Luo, Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160163/
https://www.ncbi.nlm.nih.gov/pubmed/30235712
http://dx.doi.org/10.1097/MD.0000000000012404
_version_ 1783358714232700928
author Lu, Qiang
Dong, Chun-shan
Yu, Jun-Ma
Sun, Hao
Sun, Peng
Ma, Xiang
Luo, Chun
author_facet Lu, Qiang
Dong, Chun-shan
Yu, Jun-Ma
Sun, Hao
Sun, Peng
Ma, Xiang
Luo, Chun
author_sort Lu, Qiang
collection PubMed
description Visceral pain is common during epidural anesthesia with mini dose local anesthetics in parturients during cesarean section. To reduce or avoid this complication caused by traction on the abdominal viscera, this study aimed to determine the 50% effective dose (ED(50)) and 95% effective dose (ED(95)) of epidural sufentanil as an adjuvant combination with local anesthetics for relief visceral pain in parturients with scarred uterus undergoing elective cesarean section. One hundred parturients with scarred uterus undergoing elective cesarean section under epidural anesthesia were enrolled in this randomized, double-blinded, dose-ranging study. Parturients received 5, 10, 15, 20, and 25 μg epidural sufentanil as an adjuvant with 10 mL of 0.65% ropivacaine. Successful epidural anesthesia was defined as a sixth thoracic vertebra (T(6)) sensory level achieved within 20 minutes after epidural drugs administration and/or no visceral pain by traction on the abdominal viscera during the cesarean section. The ED(50) and ED(95) were calculated with a logistic regression model. ED(50) and ED(95) of epidural sufentanil for successful of the pain-free from visceral pain were 10.7 μg [95% confidence interval (CI): 2.4–14.4 μg) and 28.1 μg (95% CI: 19.4–44.0 μg), respectively. The onset time to sensory block, maximum Bromage scale and duration of motor block were significant different with dose of sufentanil >20 μg (P < .05, compared with the other dose groups). With the dose of epidural sufentanil >20 μg could result in an increase of incidence of maternals’ adverse effects. Compared with a different dose of sufentanil, epidural administed sufentanil between 15 μg and 20 μg can maximize parturients’ satisfaction. Our study showed that sufentanil could be used in combination with ropivacaine for relief from somato-visceral pain in patients with scarred uterus during elective cesarean section during epidural anesthesia, and that maximized parturients’ satisfaction could be achieved when the use of sufentanil with the dose between 15 μg and 20 μg for epidural anesthesia.
format Online
Article
Text
id pubmed-6160163
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-61601632018-10-12 The dose response of sufentanil as an adjuvant to ropivacaine in cesarean section for relief from somato-visceral pain under epidural anesthesia in parturients with scarred uterus Lu, Qiang Dong, Chun-shan Yu, Jun-Ma Sun, Hao Sun, Peng Ma, Xiang Luo, Chun Medicine (Baltimore) Research Article Visceral pain is common during epidural anesthesia with mini dose local anesthetics in parturients during cesarean section. To reduce or avoid this complication caused by traction on the abdominal viscera, this study aimed to determine the 50% effective dose (ED(50)) and 95% effective dose (ED(95)) of epidural sufentanil as an adjuvant combination with local anesthetics for relief visceral pain in parturients with scarred uterus undergoing elective cesarean section. One hundred parturients with scarred uterus undergoing elective cesarean section under epidural anesthesia were enrolled in this randomized, double-blinded, dose-ranging study. Parturients received 5, 10, 15, 20, and 25 μg epidural sufentanil as an adjuvant with 10 mL of 0.65% ropivacaine. Successful epidural anesthesia was defined as a sixth thoracic vertebra (T(6)) sensory level achieved within 20 minutes after epidural drugs administration and/or no visceral pain by traction on the abdominal viscera during the cesarean section. The ED(50) and ED(95) were calculated with a logistic regression model. ED(50) and ED(95) of epidural sufentanil for successful of the pain-free from visceral pain were 10.7 μg [95% confidence interval (CI): 2.4–14.4 μg) and 28.1 μg (95% CI: 19.4–44.0 μg), respectively. The onset time to sensory block, maximum Bromage scale and duration of motor block were significant different with dose of sufentanil >20 μg (P < .05, compared with the other dose groups). With the dose of epidural sufentanil >20 μg could result in an increase of incidence of maternals’ adverse effects. Compared with a different dose of sufentanil, epidural administed sufentanil between 15 μg and 20 μg can maximize parturients’ satisfaction. Our study showed that sufentanil could be used in combination with ropivacaine for relief from somato-visceral pain in patients with scarred uterus during elective cesarean section during epidural anesthesia, and that maximized parturients’ satisfaction could be achieved when the use of sufentanil with the dose between 15 μg and 20 μg for epidural anesthesia. Wolters Kluwer Health 2018-09-21 /pmc/articles/PMC6160163/ /pubmed/30235712 http://dx.doi.org/10.1097/MD.0000000000012404 Text en Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle Research Article
Lu, Qiang
Dong, Chun-shan
Yu, Jun-Ma
Sun, Hao
Sun, Peng
Ma, Xiang
Luo, Chun
The dose response of sufentanil as an adjuvant to ropivacaine in cesarean section for relief from somato-visceral pain under epidural anesthesia in parturients with scarred uterus
title The dose response of sufentanil as an adjuvant to ropivacaine in cesarean section for relief from somato-visceral pain under epidural anesthesia in parturients with scarred uterus
title_full The dose response of sufentanil as an adjuvant to ropivacaine in cesarean section for relief from somato-visceral pain under epidural anesthesia in parturients with scarred uterus
title_fullStr The dose response of sufentanil as an adjuvant to ropivacaine in cesarean section for relief from somato-visceral pain under epidural anesthesia in parturients with scarred uterus
title_full_unstemmed The dose response of sufentanil as an adjuvant to ropivacaine in cesarean section for relief from somato-visceral pain under epidural anesthesia in parturients with scarred uterus
title_short The dose response of sufentanil as an adjuvant to ropivacaine in cesarean section for relief from somato-visceral pain under epidural anesthesia in parturients with scarred uterus
title_sort dose response of sufentanil as an adjuvant to ropivacaine in cesarean section for relief from somato-visceral pain under epidural anesthesia in parturients with scarred uterus
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160163/
https://www.ncbi.nlm.nih.gov/pubmed/30235712
http://dx.doi.org/10.1097/MD.0000000000012404
work_keys_str_mv AT luqiang thedoseresponseofsufentanilasanadjuvanttoropivacaineincesareansectionforrelieffromsomatovisceralpainunderepiduralanesthesiainparturientswithscarreduterus
AT dongchunshan thedoseresponseofsufentanilasanadjuvanttoropivacaineincesareansectionforrelieffromsomatovisceralpainunderepiduralanesthesiainparturientswithscarreduterus
AT yujunma thedoseresponseofsufentanilasanadjuvanttoropivacaineincesareansectionforrelieffromsomatovisceralpainunderepiduralanesthesiainparturientswithscarreduterus
AT sunhao thedoseresponseofsufentanilasanadjuvanttoropivacaineincesareansectionforrelieffromsomatovisceralpainunderepiduralanesthesiainparturientswithscarreduterus
AT sunpeng thedoseresponseofsufentanilasanadjuvanttoropivacaineincesareansectionforrelieffromsomatovisceralpainunderepiduralanesthesiainparturientswithscarreduterus
AT maxiang thedoseresponseofsufentanilasanadjuvanttoropivacaineincesareansectionforrelieffromsomatovisceralpainunderepiduralanesthesiainparturientswithscarreduterus
AT luochun thedoseresponseofsufentanilasanadjuvanttoropivacaineincesareansectionforrelieffromsomatovisceralpainunderepiduralanesthesiainparturientswithscarreduterus
AT luqiang doseresponseofsufentanilasanadjuvanttoropivacaineincesareansectionforrelieffromsomatovisceralpainunderepiduralanesthesiainparturientswithscarreduterus
AT dongchunshan doseresponseofsufentanilasanadjuvanttoropivacaineincesareansectionforrelieffromsomatovisceralpainunderepiduralanesthesiainparturientswithscarreduterus
AT yujunma doseresponseofsufentanilasanadjuvanttoropivacaineincesareansectionforrelieffromsomatovisceralpainunderepiduralanesthesiainparturientswithscarreduterus
AT sunhao doseresponseofsufentanilasanadjuvanttoropivacaineincesareansectionforrelieffromsomatovisceralpainunderepiduralanesthesiainparturientswithscarreduterus
AT sunpeng doseresponseofsufentanilasanadjuvanttoropivacaineincesareansectionforrelieffromsomatovisceralpainunderepiduralanesthesiainparturientswithscarreduterus
AT maxiang doseresponseofsufentanilasanadjuvanttoropivacaineincesareansectionforrelieffromsomatovisceralpainunderepiduralanesthesiainparturientswithscarreduterus
AT luochun doseresponseofsufentanilasanadjuvanttoropivacaineincesareansectionforrelieffromsomatovisceralpainunderepiduralanesthesiainparturientswithscarreduterus